Man-Wai Lo

460 total citations
10 papers, 348 citations indexed

About

Man-Wai Lo is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Man-Wai Lo has authored 10 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Man-Wai Lo's work include Pharmacogenetics and Drug Metabolism (3 papers), Analytical Methods in Pharmaceuticals (2 papers) and Metabolism, Diabetes, and Cancer (1 paper). Man-Wai Lo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Analytical Methods in Pharmaceuticals (2 papers) and Metabolism, Diabetes, and Cancer (1 paper). Man-Wai Lo collaborates with scholars based in United States, France and China. Man-Wai Lo's co-authors include Richard Weisman, Lewis R. Goldfrank, B. Michael Silber, Sidney Riegelman, Tom Rushmore, Scott A. Waldman, Jacqueline B. McCrea, Stephen P. Spielberg, Alastair E. Cribb and David J. Schneider and has published in prestigious journals such as The American Journal of Cardiology, Clinical Pharmacology & Therapeutics and Annals of Emergency Medicine.

In The Last Decade

Man-Wai Lo

10 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Man-Wai Lo United States 8 93 73 65 59 51 10 348
Irma H. Benedek United States 10 135 1.5× 89 1.2× 40 0.6× 50 0.8× 85 1.7× 20 509
P. Anderson Sweden 13 68 0.7× 41 0.6× 40 0.6× 36 0.6× 45 0.9× 20 413
Robert J. Herman Canada 16 75 0.8× 87 1.2× 81 1.2× 22 0.4× 41 0.8× 29 594
F. Lagrange France 10 53 0.6× 88 1.2× 54 0.8× 25 0.4× 41 0.8× 47 386
C. P. Swainson United Kingdom 14 144 1.5× 97 1.3× 65 1.0× 99 1.7× 30 0.6× 43 680
E. F. S. Termond Netherlands 12 79 0.8× 24 0.3× 53 0.8× 43 0.7× 62 1.2× 25 541
Laurie S. Mauro United States 12 50 0.5× 25 0.3× 46 0.7× 65 1.1× 16 0.3× 30 421
Robert M. Stote United States 14 61 0.7× 80 1.1× 107 1.6× 27 0.5× 81 1.6× 25 702
K. K. Adjepon-Yamoah United Kingdom 12 178 1.9× 47 0.6× 70 1.1× 18 0.3× 75 1.5× 24 516
Robert D. Colucci United States 12 43 0.5× 69 0.9× 46 0.7× 41 0.7× 77 1.5× 37 500

Countries citing papers authored by Man-Wai Lo

Since Specialization
Citations

This map shows the geographic impact of Man-Wai Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man-Wai Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man-Wai Lo more than expected).

Fields of papers citing papers by Man-Wai Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man-Wai Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man-Wai Lo. The network helps show where Man-Wai Lo may publish in the future.

Co-authorship network of co-authors of Man-Wai Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Man-Wai Lo. A scholar is included among the top collaborators of Man-Wai Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man-Wai Lo. Man-Wai Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lo, Man-Wai, et al.. (2012). Atypical Mycobacterial Exit-Site Infection and Peritonitis in Peritoneal Dialysis Patients on Prophylactic Exit-Site Gentamicin Cream. Peritoneal Dialysis International. 33(3). 267–272. 32 indexed citations
4.
Schneider, David J., Howard C. Herrmann, Nasser Lakkis, et al.. (2003). Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban. The American Journal of Cardiology. 91(3). 334–336. 61 indexed citations
5.
Riffel, Kerry, et al.. (2000). Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 23(2-3). 607–616. 4 indexed citations
6.
McCrea, Jacqueline B., Alastair E. Cribb, Tom Rushmore, et al.. (1999). Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174. Clinical Pharmacology & Therapeutics. 65(3). 348–352. 59 indexed citations
7.
Spielberg, Stephen P., Jacqueline B. McCrea, Alastair E. Cribb, et al.. (1996). A mutation in CYP2C9 is responsible for decreased metabolism of losartan.. Clinical Pharmacology & Therapeutics. 59(2). 215–215. 23 indexed citations
8.
Lo, Man-Wai, et al.. (1987). The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects. European Journal of Clinical Pharmacology. 33(3). 297–301. 21 indexed citations
9.
Goldfrank, Lewis R., et al.. (1986). A dosing nomogram for continuous infusion intravenous naloxone. Annals of Emergency Medicine. 15(5). 566–570. 94 indexed citations
10.
Lo, Man-Wai, B. Michael Silber, & Sidney Riegelman. (1982). An Automated HPLC Method for the Assay of Propranolol and Its Basic Metabolites in Plasma and Urine. Journal of Chromatographic Science. 20(3). 126–131. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026